Storys zum Thema Enterprises

Folgen
Keine Story zum Thema Enterprises mehr verpassen.
Filtern
  • 08.11.2010 – 00:02

    MTVNI Corporate Communications

    Lady Gaga and Justin Bieber Top Winners at MTV EMA 2010

    London, November 7 (ots/PRNewswire) - Pop sensation Lady Gaga topped the winners at the MTV EMA 2010 in Madrid, Spain as she scooped up the awards for Best Pop, Best Female and Best Song. Hot on her platform heels was über-phenomenon Justin Bieber, who won both the prestigious Best Male category as well as Best Push Artist. MTV EMA 2010 is sponsored by the new Suzuki Swift, Calvin Klein Jeans and Dell. It was ...

  • 05.11.2010 – 09:05

    sanofi-aventis Group

    Sanofi-aventis Partners in European Atrial Fibrillation Research Consortium

    Paris, November 5 (ots/PRNewswire) - Sanofi-aventis announced today that it is a partner in a new multidisciplinary atrial fibrillation research consortium, the "European Network for Translational research in Atrial Fibrillation" (EUTRAF), which has been awarded a EUR12 million grant to engage in atrial fibrillation (AF) research. The European consortium is ...

  • 05.11.2010 – 07:44

    BNK Petroleum Inc.

    /C O R R E C T I O N -- BNK Petroleum Inc/

    Calgary, Alberta, November 5 (ots/PRNewswire) - In the news release, "BNK Petroleum inc. Reports Third Quarter 2010 Results" issued on 4 Nov 2010 06:15 GMT, by BNK Petroleum Inc TSX:BKX over PR Newswire, we are advised by a representative of the company that errors occurred in the 'Average Netback per Barrel' row of the Overview table as well as in the Statistics table where the '3RD Quarter' and 'Nine Months' ...

  • 04.11.2010 – 07:17

    BNK Petroleum Inc.

    BNK Petroleum inc. Reports Third Quarter 2010 Results

    Calgary, Alberta, November 4 (ots/PRNewswire) - OVERVIEW Three Months Ended Sept 30 Nine Months Ended Sept 30 (US$000) 2010 2009 % Change 2010 2009 % Change Earnings (Loss): $ Thousands ($30) ($3,224) 99 ($611) ($9,915) 94 $ per common share $0.00 ($0.04) 100 ($0.01) ($0.14) 93 assuming dilution ...

  • 04.11.2010 – 07:02

    sanofi-aventis Group

    Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development

    Lyon, France, November 4 (ots/PRNewswire) - Sanofi Pasteur, the vaccines division of sanofi-aventis Group , announced today that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur's dengue vaccine, the world's most clinically advanced dengue vaccine candidate(1,2), entered its first phase 3 clinical study in Australia. This study is ...